1. Home
  2. MSM vs RYTM Comparison

MSM vs RYTM Comparison

Compare MSM & RYTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MSC Industrial Direct Company Inc.

MSM

MSC Industrial Direct Company Inc.

N/A

Current Price

$119.51

Market Cap

7.0B

Sector

Industrials

ML Signal

N/A

Logo Rhythm Pharmaceuticals Inc.

RYTM

Rhythm Pharmaceuticals Inc.

N/A

Current Price

$107.47

Market Cap

5.8B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MSM
RYTM
Founded
1941
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.0B
5.8B
IPO Year
1996
2017

Fundamental Metrics

Financial Performance
Metric
MSM
RYTM
Price
$119.51
$107.47
Analyst Decision
Hold
Strong Buy
Analyst Count
6
14
Target Price
$96.20
$131.14
AVG Volume (30 Days)
557.9K
603.8K
Earning Date
04-01-2026
05-05-2026
Dividend Yield
3.45%
N/A
EPS Growth
N/A
28.34
EPS
3.12
N/A
Revenue
$3,363,817,000.00
N/A
Revenue This Year
$5.82
$55.34
Revenue Next Year
$5.26
$86.06
P/E Ratio
$39.11
N/A
Revenue Growth
4.99
N/A
52 Week Low
$78.80
$74.50
52 Week High
$130.46
$122.20

Technical Indicators

Market Signals
Indicator
MSM
RYTM
Relative Strength Index (RSI) 47.70 46.79
Support Level $118.14 $99.14
Resistance Level $127.25 $112.43
Average True Range (ATR) 2.89 4.39
MACD -0.16 -0.71
Stochastic Oscillator 40.07 17.84

Price Performance

Historical Comparison
MSM
RYTM

About MSM MSC Industrial Direct Company Inc.

Founded in 1941, MSC Industrial Direct originally manufactured and sold cutting tools to metalworking shops in New York. Through a series of acquisitions and organic expansions, MSC has grown into an industrial distribution powerhouse with a focus on specialized metalworking products and services. The firm also distributes a wide breadth of maintenance, repair, and operations supplies. MSC primarily operates in North America, where it derives over 95% of its revenue.

About RYTM Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company engaged in the development and commercialization of therapies for patients with rare neuroendocrine diseases. The company is focused on advancing its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. In addition, it has two early-stage investigational MC4R agonists in clinical development, RM-718 and bivamelagon, designed not to cause hyperpigmentation. The company is also focused on advancing potential candidates for congenital hyperinsulinism. It currently operates in two business segments: the United States, which generates maximum revenue, and International.

Share on Social Networks: